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Objectives: The Anaconda fenestrated stent graft (Vascutek, Inchinnan, United Kingdom) is a new device that can easily
be repositioned during deployment. This study evaluated its feasibility for treating abdominal aortic aneurysms with
inadequate infrarenal sealing zones.
Methods: Patients undergoing stent graft placement at two institutions in the United Kingdom were recruited.
Results: A total of 12 visceral vessels were accommodated with 8 fenestrations for renal arteries and 4 superior mesenteric artery
valleys/scallops in 4 patients. One type Ib endoleak was identified at the 1-month follow-up and successfully treated.
Conclusions: The Anaconda fenestrated stent graft device can be used for the repair of abdominal aortic aneurysms with
hostile anatomy and has acceptable immediate and short-term results. ( J Vasc Surg 2011;54:1832-8.)
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aEndovascular aneurysm repair (EVAR) has a distinct
perioperative mortality advantage compared with open re-
pair for asymptomatic abdominal aortic aneurysms (AAA).1
In addition, benefits over open repair of shorter hospital
stay, reduced surgical morbidity, and earlier return to nor-
mal activities are reported.2 The greatest limitation to
EVAR use is unfavorable aneurysm anatomy. More specif-
ically, a short (15 mm) and angulated (60°) proximal
neck, a reverse conical neck, narrow access vessels, and
inclusion of important branch vessels by the aneurysm are
all factors that preclude its more widespread use.
To circumvent this problem and enhance the applica-
bility of EVAR to more complex aneurysms, fenestrated
and branched stent grafts, which allow for the continued
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1832erfusion of renal and visceral vessels, were developed. The
arliest of these devices was successfully deployed in 1999.3
tudies have demonstrated use of fenestrated stent grafts
ig 1. An illustration of a custom fenestrated Anaconda shows
wo fenestrations for the renal arteries and superior mesenteric
rtery accommodated in the anterior valley.ave comparable perioperative mortality rates to conven-
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Volume 54, Number 6 Bungay et al 1833tional stents used in EVAR, as well as high immediate and
midterm target vessel patency rates with a low rate of
secondary interventions.4-6 Despite this, although a Con-
formité Européene mark has been obtained in Europe,
fenestrated stent grafts are still at the clinical trial phase in
the United States.
The aim of this study was to report on the feasibility of
the Anaconda fenestrated stent graft (Vascutek, Inchinnan,
United Kingdom), with its benefits of a repositionable
main body, for repairing AAAs that are anatomically unsuit-
able for conventional EVAR.
METHODS
Patient selection. Between June and November 2010,
four patients with asymptomatic high infrarenal AAA un-
Fig 2. When planning for Anaconda custom fenestrate
(SMA) to the renal arteries is measured (c). The stent graf
the relative distance from the peak to the valley (b), to allo
Table I. Outline of patient demographics, comorbidity, an
Pt Age (years) Sex Comorbidity
1 76 M NIDDM
Hypertension
Paroxysmal AF
Hyperthyroidism
AVR
Left RA stenosis
2 78 F NIDDM
CKD
Hypertension
3 79 M Ischemic heart disease
Hypertension
Smoker
PVD
Renal cell carcinoma
4 73 M Hypertension
Abdominoperineal resection for
Former smoker
AF, Atrial fibrillation; AP, anteroposterior, ASA, American Society of Anest
estimated blood loss; F, female; FEVAR, fenestrated endovascular aneurysm
mellitus; NSTEMI, non-ST elevation myocardial infarction; PVD, periphera
aAll patients had two renal fenestrations.the top of the fenestration (a) is also calculated for accurate placeerwent elective deployment of the Anaconda fenestrated
tent graft at two institutions in the United Kingdom.
ndications for fenestrated EVAR device placement in-
luded an AAA with a maximum diameter of 5.5 cm and
nfavorable neck anatomy for conventional EVAR. Unfa-
orable anatomy was defined as an aortic neck length 10
m, a conical neck, or an aneurysm that involved the
isceral vessels.
All patients underwent preoperative assessment of their
AA using multislice high-resolution spiral computed to-
ography angiography (CTA). Images were taken from
he distal descending thoracic aorta to the proximal super-
cial femoral artery. Multiplanar and three-dimensional
orkstation reconstructions were used to evaluate the anat-
my of the aneurysm. The decision to perform fenestrated
vices, the distance from the superior mesenteric artery
n takes into consideration the oversize of the device and
w to the SMA. The distance from the peak of the device to
tcome after fenestrated stent graft placementa
ASA
score
AAA AP
diameter (mm)
Indications for
FEVAR
3 74 Juxtarenal
2 91 Short neck
3 64 Juxtarenal
2 56 Short neck
rectal cancer
ogists; AVR, aortic valve replacement; CKD, chronic kidney disease; EBL,
r; LOS, length of stay; M, male; NIDDM, non–insulin-dependent diabetes
lar disease; RA, renal artery; SMA, superior mesenteric artery.d de
t desig
w flod ou
colo
hesiol
repaiment below the sealing zone in the suprarenal aorta.
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each patient. Devices were customized to include fenestra-
tions for visceral vessels that were regarded as essential and
could not be excluded (Fig 1). Informed consent was
obtained preoperatively for all patients.
Technical aspects of the Anaconda AAA stent graft
system. The device is customized for individual patient use
and based on the design of the Conformité Européene
approved Anaconda AAA stent graft system (Fig 2). The
peaks of the ring stent device are placed suprarenally in a
lateral position (in contrast to conventional deployment in
which the peaks are positioned anteriorly and posteriorly),
allowing flow to the superior mesenteric artery (SMA),
which sits in the anteriorly oriented valley. The depth of the
valley can be adjusted with the amount of oversize between
the native vessel and the ring stent diameter or, in the case
of one patient in this series, with an augmented anterior
valley/scallop because the distance between the SMA and
renal arteries was 5 mm.
The fenestrations are placed in the unsupported region
of the graft body and therefore their positioning is not
compromised by any stents or wires. Each fenestration is
supported with a nitinol ring stent. The Anaconda custom
fenestrated body can be repositioned. Hence, even after
complete unsheathing of the device, the physician is still
able to partially collapse and change the orientation or
height of the stent graft and therefore correct for any
mismatch between the fenestrations and the target vessel
ostia.
Stent graft planning. Planning for the fenestrated
Anaconda was performed from CTA, as with standard
infrarenal EVAR. The orientation and level of the celiac,
SMA, and renal arteries were all considered. Before implan-
Table I. Continued.
Infrarenal neck
length (mm)
Method of SMA
accommodation
EBL
(mL)
Contra
volume (m
0 Valley 500 200
3 Valley 300 200
0 Valley 580 65
5 Augmented valley 360 250tation, prototype grafts made for all four patients were meployed into plastic models of the aorta created from the
T data to verify correct positioning of the fenestrations
nd clearance of the SMA ostia.
Stent graft placement. All procedures occurred in the
nterventional radiology suite with the patients under gen-
ral anesthesia. An arterial catheter and urinary catheter
ere placed perioperatively for monitoring purposes. Pa-
ients were admitted to a high-dependency unit after the
rocedure.
All patients received 5000 U of heparin intravenously
mmediately before femoral artery cannulation, with addi-
ional boluses of heparin given as required, or as a contin-
ous infusion adjusted according to the intraoperative ac-
ivated clotting time (ACT) values. The Anaconda stent
raft system used in this study is a modular device com-
osed of a fenestrated main body and two iliac extension
imbs. Bilateral open femoral artery exposure allowed for
ccess for the stent graft deployment system. The main
ody of the graft was initially deployed, followed by can-
ulation of the fenestrations with subsequent Atrium
12 (Atrium, Hudson, NH) covered stent placement
ithin the renal arteries. To aid orientation and facilitate
ccurate alignment, as well as identify fenestrations, the
naconda fenestrated stent graft device has radiopaque
arkers. Imaging was performed using a C-arm, and a
ompletion angiography was performed in all patients
fter stent graft placement to ensure adequate exclusion
f the aneurysm.
Follow-up. After stent graft placement, patients
ere studied prospectively. Postoperatively, endograft
lacement was assessed clinically and using Doppler
ltrasound imaging. When potential complications were
concern, a CTA was undertaken. Laboratory assess-
Screening
time (minutes) Peri-op complications
LOS
(days)
80 Type Ib endoleak 8
78 Bilateral groin hematomas 8
53 Complete heart block 16
NSTEMI
Heart failure
Groin hematoma
59 None 3st
L)ent of renal function was performed routinely in all
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hospital were entered into a surveillance program with
follow-up at 1 month, 6 months, and 1 year with blood
tests for assessment of renal function and CTA of the
aortic stent graft.
RESULTS
Demographic data. Four patients (three men, one
woman) underwent Anaconda fenestrated stent graft place-
ment. Patients were of American Society of Anesthesiology
(ASA) grade 2 or 3, and their comorbidities and demo-
graphic data are summarized in Table I. The patients were
a mean age of 76.5 years (range, 73-79 years). The mean
neck length was 2 mm (range, 0-5 mm). The mean diam-
eter of the supra-renal sealing zone was 28.5 mm (range,
26-31 mm; Table II). One patient had a moderate neck
angulation of 50°, but no patient had a severe (60°)
angulation of the proximal neck or thrombus involving
more than two-thirds of the proximal landing zone
diameter. Indications for fenestrated EVAR included a
short neck in two patients, a juxtarenal aneurysm in two,
and a conical neck in one. Mean maximum aneurysm
diameter was 71 mm (range, 56-91 mm). The proximal
graft diameter, sizing of fenestrations and Atrium V12
covered stents, and length of the sealing zones are de-
tailed in Table II. All of the Atrium stents were postdi-
lated/flared at the fenestration to create a seal between
the Atrium and Anaconda stent grafts. The proximal
neck did not undergo any molding in any of the patients
described.
Mean procedure time was 261 minutes (range, 181-
315 minutes), mean fluoroscopy time was 67.5 minutes
(range, 53-80 minutes), and 179 mL of iodinated contrast
(range, 65-250 mL) was used per case (Table I).
Eight fenestrations with covered stents for renal arteries
and four SMA valleys/scallops were used. Selective cathe-
ters were used to localize and catheterize branch vessels,
and the target vessel cannulation success rate was 100%. All
target branch vessels remained perfused after the proce-
dure. In one patient, an accessory renal artery was inten-
tionally covered. Completion angiography demonstrated
successful exclusion of the aneurysm in all patients
(Figs 3-6).
Perioperative results. There were no perioperative
Table II. Technical aspects of Anaconda stent graft placem
Pt
Ring stent
size (mm)
Size
proximal
native
aorta
(mm)
Percentage
oversize (%)
Size of le
renal
fenestrati
(mm)
1 32 26 23 8
2 32 28 14 6
3 32 27 19 6
4 34 28 21 8
aPostdilated to 8 mm.deaths. The mean estimated intraoperative blood loss tas 435 mL (range, 300-580 mL). Perioperative mor-
idity included groin hematomas in two patients and
omplete heart block and myocardial infarction compli-
ated by heart failure in one patient. The mean inpatient
ospital length of stay was 8.75 days (range, 3-16 days;
able I). There was no difference in preoperative or
ostoperative serum creatinine levels (P  .42), and no
atient required dialysis.
Follow-up. All patients have undergone 1-month
ollow-up, and no patient has been lost to follow-up. No
neurysm-related or aneurysm-unrelated deaths have
een reported. One patient had CTA evidence of a type Ib
ndoleak and underwent balloon angioplasty of the right iliac
ealing zone, with successful resolution of the endoleak.
enal function remained unchanged at follow-up (P 
30), and no target vessels were occluded. Patient 1 has
lso had 6-month follow-up and is well, with all stents
atent, no endoleak, and preserved renal function.
ISCUSSION
Fenestrated endovascular stent grafts offer patients
ho are likely to be at high risk for surgery because of a
ostile aneurysm anatomy,4 a therapeutic option that has
ower perioperative mortality rates compared with open
epair.6 Each stent graft is tailored to the individual
atient, and therefore, careful planning and collabora-
ion with the manufacturer is required. This currently
recludes their use for the treatment of ruptured or
ymptomatic AAAs. Furthermore, fenestrated stent graft
eployment requires expertise and should be performed
y a team familiar with the stent graft device and its
eployment system.
Although this is a very small series, and long-term
ollow-up data are not yet available, immediate and short-
erm results suggest the Anaconda fenestrated stent graft is
potentially efficacious method for treating complex AAAs
hat are not suitable for conventional EVAR. Although
reater contrast volumes are required than for conven-
ional EVAR,7 no renal complications developed in the
atients in this series. In addition, all target vessels were
uccessfully cannulated, and none were lost during the
ntervention. One reason for acute branch vessel loss is
natomic factors, and these can affect the versatility of
Size of
atrium V12
covered stent
used on left
(mm)
Size of right
renal
fenestration
(mm)
Size of
atrium V12
covered stent
used on right
(mm)
Length of
sealing
zone
(mm)
7a 6 6 15
6 6 6 8
6 6 6 7
7a 8 7a 5ent
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ter, calcification, and tortuous iliac vessels are all factors
associated with acute target vessel loss and may lead to
maldeployment.4
One advantage of the Anaconda custom fenestrated
stent body is that it can be repositioned: after the device is
unsheathed, it can be partially collapsed and the orientation
or longitudinal position of the stent graft altered. This
Fig 3. A, A computed tomography angiography (CTA) recon-
struction of the 74-mm juxtarenal abdominal aortic aneurysm is
shown for patient 1. A web-like stenosis of the left renal artery is
clearly seen. B, A volume-rendered reconstruction of the 6-month
follow-up CTA shows the fenestrated graft has excluded the
aneurysm.facilitates accurate initial deployment with respect to the pisceral arteries and also allows for easy correction of any
ismatch between fenestrations and target vessels that may
rise during the procedure. Below the proximal sealing
tents, the main body of the graft consists of unsupported
abric; consequently, there is no limitation on fenestration
ize or position. This feature also simplifies stent graft
lanning and manufacture, and may make the fenestrations
nd renal stents less prone to compromise on long-term
ollow-up, even in the presence of aneurysm remodeling or
tent graft migration.
At the 1-month follow-up, all target vessels remained
ig 4. A, A computed tomography angiography (CTA) recon-
truction shows the short neck of the aneurysm in patient 2, and
50° angulation is seen in this coronal plane. B, A volume-
endered reconstruction of the 1-month follow-up CTA shows
he graft conforms to the angulated neck anatomy, patent
enal stents/arteries, and the superior mesenteric artery is ac-
ommodated within the anteriorly oriented valley of the proxi-
al graft.atent in this series. We recognize, however, that most
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term follow-up data are therefore required to fully eval-
uate target vessel patency with this device. Perioperative
morbidity in our series was also acceptable6; a type Ib
endoleak developed in one patient, which was easily
remedied. With a small series it is difficult to interpret
this event, in the context of the literature, which reports
type I and III endoleak rates of between 1.7% and
13%.5,8
CONCLUSIONS
Four patients with AAAs underwent fenestrated endo-
vascular stent graft placement using the newly developed
Vascutek Anaconda fenestrated stent graft system. A total
of 12 visceral vessels were accommodated with 8 fenestra-
Fig 5. A, A computed tomography angiography (CTA) maxi-
mum intensity projection (MIP) image for patient 3 shows the
neck anatomy before fenestrated endovascular aneurysm repair
(FEVAR). B, A CTA MIP image shows the position of the stent
graft and renal artery stents after FEVAR.tions for renal arteries and 4 SMA valleys/scallops. One Cype Ib endoleak was identified at follow-up, and this was
uccessfully treated with balloon dilatation.
From this preliminary study, we conclude that the
naconda fenestrated stent graft device is feasible for the
epair of AAAs with hostile neck anatomy that renders them
nsuitable for conventional EVAR. The unique advantage
he Anaconda stent graft has over conventional EVAR is
he ability to be repositioned, which allows for accurate
nitial deployment of the device and facilitates adjustment
f the stent graft main body and fenestrations to allow for
orrection, if required, of target vessel to fenestration mis-
lignment during the procedure.
We would like to thank Ian Franklin, Consultant Vas-
ular Surgeon, Imperial College Healthcare NHS Trust,
nd David Nott, Consultant Vascular Surgeon, Imperial
ig 6. A, A computed tomography angiography (CTA) maxi-
um intensity projection (MIP) in patient 4 shows the neck
natomy before fenestrated endovascular aneurysm repair
FEVAR). B, The CTA MIP image shows the position of the
tent graft and renal artery stents after FEVAR.ollege Healthcare NHS Trust.
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